82 related articles for article (PubMed ID: 22911331)
1. The Development of MST Test Information for the Prediction of Test Performances.
Park R; Kim J; Chung H; Dodd BG
Educ Psychol Meas; 2017 Aug; 77(4):570-586. PubMed ID: 30034020
[TBL] [Abstract][Full Text] [Related]
2. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.
Sharma A; Smyrk TC; Levy MJ; Topazian MA; Chari ST
Gastroenterology; 2018 Aug; 155(2):490-500.e2. PubMed ID: 29723506
[TBL] [Abstract][Full Text] [Related]
3. CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies.
Prakash MK; Lang B; Heinrich H; Valli PV; Bauerfeind P; Sonnenberg A; Beerenwinkel N; Misselwitz B
BMC Med Inform Decis Mak; 2017 Jun; 17(1):80. PubMed ID: 28583127
[TBL] [Abstract][Full Text] [Related]
4. Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.
Garcia M; Domènech X; Vidal C; Torné E; Milà N; Binefa G; Benito L; Moreno V
Gastroenterol Res Pract; 2015; 2015():672410. PubMed ID: 25802515
[TBL] [Abstract][Full Text] [Related]
5. Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis?
Biswas M; Ades AE; Hamilton W
Br J Cancer; 2015 Jan; 112(2):271-7. PubMed ID: 25461802
[TBL] [Abstract][Full Text] [Related]
6. Estimated mean sojourn time associated with hemoccult SENSA for detection of proximal and distal colorectal cancer.
Zheng W; Rutter CM
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1722-30. PubMed ID: 22911331
[TBL] [Abstract][Full Text] [Related]
7. A comparison of fecal occult-blood tests for colorectal-cancer screening.
Allison JE; Tekawa IS; Ransom LJ; Adrain AL
N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of new occult blood tests for detection of colorectal neoplasia.
St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
[TBL] [Abstract][Full Text] [Related]
9. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
Rozen P; Knaani J; Samuel Z
Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
[TBL] [Abstract][Full Text] [Related]
10. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.
Zauber AG; Winawer SJ; O'Brien MJ; Lansdorp-Vogelaar I; van Ballegooijen M; Hankey BF; Shi W; Bond JH; Schapiro M; Panish JF; Stewart ET; Waye JD
N Engl J Med; 2012 Feb; 366(8):687-96. PubMed ID: 22356322
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy in colon cancer.
Graham JS; Cassidy J
Expert Rev Anticancer Ther; 2012 Jan; 12(1):99-109. PubMed ID: 22149436
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
